All content for International Journal of Stroke: Podcast Series is the property of International Journal of Stroke and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The International Journal of Stroke podcast offers interviews with key figures in the field and highlights of current topics and issues.
Antagonizing Dabigatran by Idarucizumab in Cases of Ischemic Stroke or Intracranial Hemorrhage in Germany – Updated Series of 120 Cases: Pawel Kermer
International Journal of Stroke: Podcast Series
13 minutes 3 seconds
5 years ago
Antagonizing Dabigatran by Idarucizumab in Cases of Ischemic Stroke or Intracranial Hemorrhage in Germany – Updated Series of 120 Cases: Pawel Kermer
Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatran treatment may become eligible for thrombolysis with rt-PA. In patients on dabigatran with intracerebral hemorrhage idarucizumab could prevent lesion growth. Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke spoke to Dr Pawel Kermer from Krankenhaus Sanderbusch; Neurology, Sande Germany.
Read the article link here
International Journal of Stroke: Podcast Series
The International Journal of Stroke podcast offers interviews with key figures in the field and highlights of current topics and issues.
